{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:23:25Z","timestamp":1772929405247,"version":"3.50.1"},"reference-count":22,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.25-0799","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:09:04Z","timestamp":1772748544000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Catastrophic Esophageal Tumor Perforation within One Week after First-Line Chemo-Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: A Case Report"],"prefix":"10.70352","volume":"12","author":[{"given":"Takeshi","family":"Matsubara","sequence":"first","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Kaji","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayana","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Ishitobi","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahito","family":"Taniura","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Hidaka","sequence":"additional","affiliation":[{"name":"Department of Digestive and General Surgery, Shimane University, Izumo, Shimane, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nachira D, Sassorossi C, Petracca-Ciavarella L, et al. Management of esophageal perforations and postoperative leaks. Ann Esophagus 2023; 6: 10.","DOI":"10.21037\/aoe-2020-23"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Chen C, Fu X, Dai Y, et al. Impact of extracapsular lymph node involving the esophagus in esophageal perforation during and after radiotherapy: a propensity score-matched analysis. Cancer Manag Res 2020; 12: 6541\u201351.","DOI":"10.2147\/CMAR.S265273"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sun JM, Shen L, Shah MA, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet 2021; 398: 759\u201371.","DOI":"10.1016\/S0140-6736(21)01234-4"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kobayashi T, Makino T, Yamasaki M, et al. Successful stenting followed by surgery for perforated esophageal cancer due to chemotherapy. Ann Thorac Surg 2019; 108: e361\u20133.","DOI":"10.1016\/j.athoracsur.2019.04.022"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Mine S, Tanaka K, Kawachi H, et al. Japanese Classification of Esophageal Cancer, 12th Edition: Part I. Esophagus 2024; 21: 179\u2013215.","DOI":"10.1007\/s10388-024-01054-y"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Doki Y, Tanaka K, Kawachi H, et al. Japanese Classification of Esophageal Cancer, 12th Edition: Part II. Esophagus 2024; 21: 216\u201369.","DOI":"10.1007\/s10388-024-01048-w"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Pao TH, Chen YY, Chang WL, et al. Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma. PLoS One 2021; 16: e0251811.","DOI":"10.1371\/journal.pone.0251811"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Zhu C, Wang S, You Y, et al. Risk factors for esophageal fistula in esophageal cancer patients treated with radiotherapy: a systematic review and meta-analysis. Oncol Res Treat 2020; 43: 34\u201341.","DOI":"10.1159\/000503754"},{"key":"9","unstructured":"9) Shimomatsuya T, Hashimoto K, Nakamura S, et al. A case of perforation of unresectable esophageal cancer during nivolumab therapy (in Japanese). Gan To Kagaku Ryoho 2022; 49: 1105\u20137."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shaqran TM, Engineer R, Abdalla EM, et al. The management of esophageal perforation: a systematic review. Cureus 2024; 16: e63651.","DOI":"10.7759\/cureus.63651"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Schweigert M, Sousa HS, Solymosi N, et al. Spotlight on esophageal perforation: a multinational study using the Pittsburgh esophageal perforation severity scoring system. J Thorac Cardiovasc Surg 2016; 151: 1002\u201311.","DOI":"10.1016\/j.jtcvs.2015.11.055"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ferri L, Lee JK-T, Law S, et al. Management of spontaneous perforation of esophageal cancer with covered self expanding metallic stents. Dis Esophagus 2005; 18: 67\u20139.","DOI":"10.1111\/j.1442-2050.2005.00453.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gray KE, Sarode A, Jiang B, et al. Surgical repair vs stent for esophageal perforation: a multi-institutional database analysis. Ann Thorac Surg 2023; 115: 1378\u201384.","DOI":"10.1016\/j.athoracsur.2022.07.023"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Han X, Zhao YS, Fang Y, et al. Placement of transnasal drainage catheter and covered esophageal stent for the treatment of perforated esophageal carcinoma with mediastinal abscess. J Surg Oncol 2016; 114: 725\u201330.","DOI":"10.1002\/jso.24384"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Luttikhold J, Pattynama LMD, Seewald S, et al. Endoscopic vacuum therapy for esophageal perforation: a multicenter retrospective cohort study. Endoscopy 2023; 55: 859\u201364.","DOI":"10.1055\/a-2042-6707"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Champiat S, Dercle L, Ammari S, et al. Hyperprogressive disease is a new pattern of progression in cancer patients treated by anti-PD-1\/PD-L1. Clin Cancer Res 2017; 23: 1920\u20138.","DOI":"10.1158\/1078-0432.CCR-16-1741"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kim CG, Kim KH, Pyo KH, et al. Hyperprogressive disease during PD-1\/PD-L1 blockade in patients with non-small-cell lung cancer. Ann Oncol 2019; 30: 1104\u201313.","DOI":"10.1093\/annonc\/mdz123"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Champiat S, Ferrara R, Massard C, et al. Hyperprogressive disease: recognizing a novel pattern to improve patient management. Nat Rev Clin Oncol 2018; 15: 748\u201362.","DOI":"10.1038\/s41571-018-0111-2"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ferrara R, Mezquita L, Texier M, et al. Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1\/PD-L1 inhibitors or with single-agent chemotherapy. JAMA Oncol 2018; 4: 1543\u201352.","DOI":"10.1001\/jamaoncol.2018.3676"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Ohsawa M, Hamai Y, Ibuki Y, et al. Successful management of esophageal cancer with perforation using bypass surgery followed by definitive chemoradiotherapy. In Vivo 2020; 34: 2169\u201372.","DOI":"10.21873\/invivo.12025"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Griffiths EA, Yap N, Poulter J, et al. Thirty-four cases of esophageal perforation: the experience of a district general hospital in the UK. Dis Esophagus 2009; 22: 616\u201325.","DOI":"10.1111\/j.1442-2050.2009.00959.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Chen H, Ma X, Ye M, et al. Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma. J Radiat Res 2014; 55: 940\u20137.","DOI":"10.1093\/jrr\/rru031"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.25-0799\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:01:46Z","timestamp":1772859706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.25-0799\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.25-0799","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.25-0799"}}